# HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Study · id `cardio:ct-nct04722796` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04722796](<https://clinicaltrials.gov/study/NCT04722796>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04722796

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 508 participants.

## Technical summary

Registry record NCT04722796. Randomized; double masking; primary purpose treatment. Start 2021-04-12 (actual); primary completion 2024-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 508 participants (planned count; ClinicalTrials.gov record NCT04722796, source copy `cardio:ctgov-nct04722796-2021-06-02`, retrieved 2026-10-26)
- Started: 2021-04-12 (actual) (ClinicalTrials.gov record NCT04722796, source copy `cardio:ctgov-nct04722796-2021-06-02`, retrieved 2026-10-26)
- Primary completion: 2024-04-01 (anticipated) (ClinicalTrials.gov record NCT04722796, source copy `cardio:ctgov-nct04722796-2021-06-02`, retrieved 2026-10-26)
- Completion: 2028-04-01 (anticipated) (ClinicalTrials.gov record NCT04722796, source copy `cardio:ctgov-nct04722796-2021-06-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04722796, source copy `cardio:ctgov-nct04722796-2021-06-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04722796-2021-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: HANGZHOU Solution in Bicuspid AS Undergoing TAVR
- Condition: Aortic Stenosis
- Condition: Aortic Stenosis With Bicuspid Valve
- Intervention (Device): TAVR with Venus A plus using supra-annular sizing and THV implantation technique (Hangzhou solution)
- Intervention (Device): TAVR with Venus A plus using annular sizing and THV implantation technique
- Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Lead sponsor class: OTHER
- Collaborator: Venus MedTech (HangZhou) Inc.
- Collaborator class: INDUSTRY
- Collaborator: The First Affiliated Hospital of Bengbu Medical University
- Collaborator class: OTHER
- Collaborator: Chinese PLA General Hospital
- Collaborator class: OTHER
- Collaborator: Fujian Medical University Union Hospital
- Collaborator class: OTHER
- Collaborator: Xiamen University Affiliated Cardiovascular Hospital
- Collaborator class: UNKNOWN
- Collaborator: The Second People's Hospital of GuangDong Province
- Collaborator class: OTHER
- Collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Zhengzhou University
- Collaborator class: OTHER
- Collaborator: Henan Provincial Chest Hospital
- Collaborator class: OTHER
- Collaborator: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Collaborator class: OTHER
- Collaborator: Central South University
- Collaborator class: OTHER
- Collaborator: Northern Jiangsu People's Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Nanchang University
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital of Nanchang University
- Collaborator class: OTHER
- Collaborator: The Affiliated Hospital of Qingdao University
- Collaborator class: OTHER
- Collaborator: Shanxi Cardiovascular Hospital
- Collaborator class: OTHER
- Collaborator: Tianjin Chest Hospital
- Collaborator class: OTHER
- Collaborator: Ning Bo First Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 14 registry organizations

## Provenance

Content hash: fc7e27602c02af954a4c30a088d9c563f12d2d3269a1bfa04b79ad5ba48eaa47
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
